NK1 receptor antagonism and emotional processing in healthy volunteers.
The neurokinin-1 (NK(1)) receptor antagonist, aprepitant, showed activity in several animal models of depression; however, its efficacy in clinical trials was disappointing. There is little knowledge of the role of NK(1) receptors in human emotional behaviour to help explain this discrepancy. The ai...
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Journal article |
| Γλώσσα: | English |
| Έκδοση: |
2010
|
| _version_ | 1826284021264416768 |
|---|---|
| author | Chandra, P Hafizi, S Massey-Chase, R Goodwin, G Cowen, P Harmer, C |
| author_facet | Chandra, P Hafizi, S Massey-Chase, R Goodwin, G Cowen, P Harmer, C |
| author_sort | Chandra, P |
| collection | OXFORD |
| description | The neurokinin-1 (NK(1)) receptor antagonist, aprepitant, showed activity in several animal models of depression; however, its efficacy in clinical trials was disappointing. There is little knowledge of the role of NK(1) receptors in human emotional behaviour to help explain this discrepancy. The aim of the current study was to assess the effects of a single oral dose of aprepitant (125 mg) on models of emotional processing sensitive to conventional antidepressant drug administration in 38 healthy volunteers, randomly allocated to receive aprepitant or placebo in a between groups double blind design. Performance on measures of facial expression recognition, emotional categorisation, memory and attentional visual-probe were assessed following the drug absorption. Relative to placebo, aprepitant improved recognition of happy facial expressions and increased vigilance to emotional information in the unmasked condition of the visual probe task. In contrast, aprepitant impaired emotional memory and slowed responses in the facial expression recognition task suggesting possible deleterious effects on cognition. These results suggest that while antagonism of NK(1) receptors does affect emotional processing in humans, its effects are more restricted and less consistent across tasks than those of conventional antidepressants. Human models of emotional processing may provide a useful means of assessing the likely therapeutic potential of new treatments for depression. |
| first_indexed | 2024-03-07T01:07:36Z |
| format | Journal article |
| id | oxford-uuid:8be065d1-a190-46c4-b6c2-04720d003412 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:07:36Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | oxford-uuid:8be065d1-a190-46c4-b6c2-04720d0034122022-03-26T22:41:03ZNK1 receptor antagonism and emotional processing in healthy volunteers.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8be065d1-a190-46c4-b6c2-04720d003412EnglishSymplectic Elements at Oxford2010Chandra, PHafizi, SMassey-Chase, RGoodwin, GCowen, PHarmer, CThe neurokinin-1 (NK(1)) receptor antagonist, aprepitant, showed activity in several animal models of depression; however, its efficacy in clinical trials was disappointing. There is little knowledge of the role of NK(1) receptors in human emotional behaviour to help explain this discrepancy. The aim of the current study was to assess the effects of a single oral dose of aprepitant (125 mg) on models of emotional processing sensitive to conventional antidepressant drug administration in 38 healthy volunteers, randomly allocated to receive aprepitant or placebo in a between groups double blind design. Performance on measures of facial expression recognition, emotional categorisation, memory and attentional visual-probe were assessed following the drug absorption. Relative to placebo, aprepitant improved recognition of happy facial expressions and increased vigilance to emotional information in the unmasked condition of the visual probe task. In contrast, aprepitant impaired emotional memory and slowed responses in the facial expression recognition task suggesting possible deleterious effects on cognition. These results suggest that while antagonism of NK(1) receptors does affect emotional processing in humans, its effects are more restricted and less consistent across tasks than those of conventional antidepressants. Human models of emotional processing may provide a useful means of assessing the likely therapeutic potential of new treatments for depression. |
| spellingShingle | Chandra, P Hafizi, S Massey-Chase, R Goodwin, G Cowen, P Harmer, C NK1 receptor antagonism and emotional processing in healthy volunteers. |
| title | NK1 receptor antagonism and emotional processing in healthy volunteers. |
| title_full | NK1 receptor antagonism and emotional processing in healthy volunteers. |
| title_fullStr | NK1 receptor antagonism and emotional processing in healthy volunteers. |
| title_full_unstemmed | NK1 receptor antagonism and emotional processing in healthy volunteers. |
| title_short | NK1 receptor antagonism and emotional processing in healthy volunteers. |
| title_sort | nk1 receptor antagonism and emotional processing in healthy volunteers |
| work_keys_str_mv | AT chandrap nk1receptorantagonismandemotionalprocessinginhealthyvolunteers AT hafizis nk1receptorantagonismandemotionalprocessinginhealthyvolunteers AT masseychaser nk1receptorantagonismandemotionalprocessinginhealthyvolunteers AT goodwing nk1receptorantagonismandemotionalprocessinginhealthyvolunteers AT cowenp nk1receptorantagonismandemotionalprocessinginhealthyvolunteers AT harmerc nk1receptorantagonismandemotionalprocessinginhealthyvolunteers |